Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease

Orr, M.E., Gonzales, M.M., Garbarino, V.R., Kautz, T.F., Palavicini, J.P., Lopez‐Cruzan, M., Dehkordi, S.K., Mathews, J., Zare, H., Xu, P., Zhang, B., Franklin, C., Habes, M., Craft, S., Petersen, R.C., Tchkonia, T., Kirkland, J.L., Salardini, A., Seshadri, S., &amp; Musi, N. (2023). Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-2809973/v1

Orr ME, Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, Lopez‐Cruzan M, et al. Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. Research Square. 2023. doi:10.21203/rs.3.rs-2809973/v1.

@unpublished{miranda2023Senoly, title = {Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease}, author = {Miranda E. Orr and Mitzi M. Gonzales and Valentina R. Garbarino and Tiffany F. Kautz and Juan Pablo Palavicini and Marisa Lopez‐Cruzan and Shiva Kazempour Dehkordi and Julia Mathews and Habil Zare and Peng Xu and Bin Zhang and Crystal Franklin and Mohamad Habes and Suzanne Craft and Ronald C. Petersen and Tamar Tchkonia and James L. Kirkland and Arash Salardini and Sudha Seshadri and Nicolas Musi}, journal = {Research Square}, year = {2023}, doi = {10.21203/rs.3.rs-2809973/v1}, }